Discover Magazine6 小时
There's a Growing Number of Lung Cancer Cases From People Who’ve Never Smoked
Air pollution might be playing an increasing role in causing the disease.
appliedclinicaltrialsonline13 小时
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...
‘It’s working!’ Columbus cancer center is first in Georgia to administer this new therapy
Susan Williams,seated center, a patient at the John B. Amos Cancer Center in Columbus, Georgia, is receiving a new cancer ...
Immunotherapy reduces sunspots by 65% in cancer patients
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
Piper Sandler sets $84 target on Merus stock, cites drug potential
Piper Sandler initiated coverage on Merus N.V. (NASDAQ:MRUS), a $2.8 billion market cap biotech company, with an Overweight rating and a price target of $84.00. According to InvestingPro data, the ...
Medscape12 小时
Endometrial Cancer Disparities: Improving Black Women's Access to Care and Trials
Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.
Medindia21 小时
Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At ...
Cancers Symposium 2025, to be held in San Francisco, USA, from Feb. 13-15, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd ("Kelun-Biotech" will present efficacy and safety results from the ...
Primary Biliary Cholangitis Clinical Trial Pipeline 20+ Companies Pioneering The Future Of ...
Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...